Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing.
29/10/2024
/
Publications
Published in the Green Journal, this study used dose-response models for predicting outcomes of chemoradiation (CRT) plus immune checkpoint blockade (ICB) for...
Sparing of the heart facilitates recovery from cardiopulmonary side effects after thoracic irradiation.
29/10/2024
/
Publications
Published in the Red Journal, this study from the Groningen group reported persistent reduction in cardiopulmonary function caused by radiation exposure of the...
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer with Extended Durvalumab Therapy (PARTICLE-D).
29/10/2024
/
Publications
This phase I dose-escalation study by the group of Cleveland Medical Center, Ohio, reported severe treatment related toxicity. A total of 7 patients with stage...
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.
30/10/2024
/
Publications
This registry study from Japan reported outcomes of 274 patients with operable lung cancer treated with proton (n=138, 50 %) and carbon ion (n=136, 50 %)...
Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis
08/07/2021
/
Publications
/
Chemotherapy
IMRT
This study retrospectively reviewed 219 patients with stage III NSCLC who received definitive concurrent chemoradiotherapy. 25 patients (11.4%) underwent PBSPT...
Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer
08/08/2021
/
Publications
/
Hypofractionation
Toxicity
A study by the NCC, Korea group. This study retrospectively analyzed 42 patients with stage I NSCLC treated with protos to an initial dose of 60 CGE in 4...
Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy.
11/03/2019
/
Publications
This study proposed and simulated a model-based methodology to incorporate heterogeneous treatment benefit of proton therapy versus photon therapy into...
Proton therapy for non-small cell lung cancer: the road ahead.
11/09/2019
/
Publications
This latest review article examined the up-to-date clinical data of PBT for both early stage and locally advanced stage NSCLC. In particular, this review...
Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System.
01/02/2020
/
Publications
/
FLASH Therapy
Published in the Red Journal by the UPenn group, this paper reported the effect of FLASH proton versus standard dose rate PRT on tumors and normal tissues in...
A population-based assessment of proton beam therapy utilization in California.
01/02/2020
/
Publications
Based on data from California Cancer Registry, this study reported that of the 2,499,510 people with a cancer diagnosis during the study period, 578,632 (23%)...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.